PK of IV Posaconazole in Critically Ill Patients

Phase 4, open-label, single-arm trial of posaconazole in fungal infection, sponsored by Royal Brisbane and Women's Hospital. Primary endpoints: Area Under the Total Plasma Concentration-time Curve From Time Zero to Infinity at 48 hours and Area Under the Unbound Concentrations-time Curve From Time Zero to Infinity at 48 hours. Started Jan 2017; status: completed.